Novo Nordisk taps Replicate Bioscience’s srRNA platform for obesity
Replicate will receive research funding and could potentially receive up to approximately US$550 million
Replicate will receive research funding and could potentially receive up to approximately US$550 million
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The company is bringing precision therapies for gynaecological cancers
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
cSCC is one of the most common cancers in the U.S. and globally
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
Subscribe To Our Newsletter & Stay Updated